Navigation Links
DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
Date:9/19/2013

afety and dosing profile over current therapies
  • Studies by the National Cancer Institute and DelMar have shown VAL-083 to have activity against a range of cancers, including glioblastoma
  • DelMar is conducting a Phase I/II clinical trial for VAL-083 at UC San Francisco and the Sarah Cannon Research Institute in Nashville, Tennessee and Sarasota, Florida
  • VAL-083 has received orphan drug designation in Europe and the U.S.
  • Additional Information:

    About DelMar Pharmaceuticals

    Del Mar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 benefits from extensive clinical research sponsored by the U.S. National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action.

    For more information, please visit www.delmarpharma.com or follow us on Twitter

    SOURCE DelMar Pharmaceuticals
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
    2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
    3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
    4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
    5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
    6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
    7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
    8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
    9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
    10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
    11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
    (Date:12/19/2014)... 18, 2014  Sage Analytics ( www.sageanalytics.com ), ... for the testing of marijuana potency and moisture ... Luminary™ Profiler, the industry,s first product suite capable ... cost-effective, portable unit. Designed from the ... the cannabis industry, the Luminary™ Profiler utilizes specially ...
    (Date:12/19/2014)... , Dec. 18, 2014 Since last month,s ... site now known as the leading online black market ... explosive growth in its offering of drugs and other ... show the takedowns did succeed in lowering the numbers ... review of the markets in August. But some new ...
    Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3
    ... HUNTINGTON BEACH, California and AMSTERDAM, ... diagnostics, announced today that,the US Food and Drug Administration ... ages. MammaPrint is the only FDA-cleared,breast cancer recurrence test ... the FDA has issued four clearances for MammaPrint, covering,all ...
    ... , SAN DIEGO, Dec. 17 Suneva Medical, a ... signed a multi-million dollar line of credit facility with Western ... be used to fund commercial support for Artefill®, the only ... well as to expand Suneva,s Aesthetic Market growth objectives. , ...
    Cached Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 3
    (Date:12/22/2014)... Branch, TX (PRWEB) December 22, 2014 ... revolutionary work glove with many useful features. Customers of ... and can have the new gloves delivered to their ... work gear and hand tools that incorporate heavy duty ... Utility Magnetic Glove allows workers to store metal parts ...
    (Date:12/22/2014)... (PRWEB) December 22, 2014 Christmas is days ... has a fast and easy solution that will please: the ... can be purchased from from $25 up to $350," says ... 100% customer satisfaction and a wide array of skin care ... fees and no expiration dates. , Gift delivery past ...
    (Date:12/22/2014)... City, NY (PRWEB) December 22, 2014 ... as a 2014 Professional Woman of the Year. She ... healthcare. As the largest, most recognized networking organization of ... and profession, the National Association of Professional Women is ... nearly 300 Local Chapters. , Ms. Kreider is passionate ...
    (Date:12/22/2014)... December 22, 2014 The ... professional development programs this month. Faculty have been ... on nurse educators fast-tracked for administrative leadership roles ... Development Program for Simulation Educators, featuring a curriculum ... of nursing education. , Twenty nurse educators ...
    (Date:12/22/2014)... December 22, 2014 Parker & Sons, ... best in Arizona home contracting services reports a record ... its quality services in 2014. As a company that ... early 1970s, Parker and Sons is a business that ... company works side-by-side with other top quality companies in ...
    Breaking Medicine News(10 mins):Health News:MagnoGrip Pro Utility Magnetic Gloves on Sale at TheHardwareCity.com 2Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3
    ... Cielo experiences explosive growth in software-as-a-service customer base , ... ... LLC, a provider of healthcare software and web applications, announces revenue ... the calendar year 2008, Cielo grew its installed base of clinician ...
    ... announced today the launch of a redesigned and ... release of their FREE 2009 full-color industrial products ... and packed with information to make the shopping ... industrial products since 1948, Reid Supply focuses on ...
    ... Globus Medical, Inc., the largest privately held ... the introduction of the PATRIOT SIGNATURE(TM) TLIF Spacer ... Spacer is the latest addition to Globus Medical,s ... Care products. The SIGNATURE(TM) TLIF Spacer system includes ...
    ... Recall to Wholesale Level on Certain Products Expanded to Retail ... KV Pharmaceutical Company (NYSE: KVa ; KVb), ... a previously announced recall on certain products. The recall ... the wholesale level, but is now being expanded to the ...
    ... and INDIANAPOLIS, Feb. 3 The U.S. Food ... voted 9,to 0 that prasugrel, an investigational antiplatelet ... with acute coronary syndromes (ACS) managed with,an artery-opening ... Company, Limited, (TSE: 4568), and Eli Lilly and ...
    ... doubt as to safety, transparency of medical research, study ... parents are more likely than white parents to distrust ... frequently underrepresented in studies. , So conclude University of ... white) who brought their children to a primary-care clinic. ...
    Cached Medicine News:Health News:Cielo MedSolutions Announces Strong Revenue Growth in 2008 2Health News:New Enhanced Web Site and Catalog from Reid Supply 2Health News:New Enhanced Web Site and Catalog from Reid Supply 3Health News:Globus Medical's SIGNATURE(TM) Spacer Designed for MILDER(TM) TLIF Procedures 2Health News:ETHEX Corporation Issues Voluntary Nationwide Recall 2Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 2Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 3Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 4Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 5Health News:Parental Distrust May Explain Lack of Black Children in Clinical Trials 2
    The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm....
    ... CO-Oximeter Control (Bayer 800 Series) is ... monitoring the performance of blood gas, ... 270 and 800 series) instrumentation. This ... Bayer 800 Rapidlab Series instruments in ...
    Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximeter (Radiometer) ...
    Liquichek Blood Gas Plus EGL Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2, electrolytes, glucose and lactate (lactic acid)....
    Medicine Products: